Novaterra’s Post

Introducing Novaterra's Human Preservation Investment Focus. At Novaterra, we are committed to investing in science and technology to address the most critical challenges of our time. Our aim is to redirect traditional capital to sustain impactful innovation. One of the two investment focuses of our thesis is #HumanPreservation: a portfolio of companies committed to improving the human condition, by curing incurable diseases, making life longer and healthier, and increasing the chances of surviving. As such, we will invest in three key areas: #LifeSciences: Our life sciences focus spans the increase of quality of life through research, development, clinical trials, and ultimately new drug manufacturing. #HealthTech: Innovation in this field leverages technology to transform healthcare delivery by improving accessibility, quality, and efficiency. #SpaceExploration: This industry has experienced remarkable innovation, turning it into one that can deeply impact humanity, by making life multi-planetary. Visit our website to learn more about how we intend to contribute to Humanity: https://lnkd.in/e7zmVwmQ #HealthTech #Novaterra

Novaterra

Novaterra

novaterra.io

Vittorio Palma

MBA | Nova111 | Corporate Venture Capital & Innovation @Terna Spa | Terna Forward | Startup

5mo

Grandi 🚀

To view or add a comment, sign in

Explore topics